FrancophonIA/ELRC3.0 huggingface dataset:
English: Adolescents weighing ≥ 51 kg: the maximum recommended daily dose of INVEGA is 12 mg.
Croatian: Adolescenti težine ≥ 51 kg: maksimalna preporučena dnevna doza lijeka INVEGA je 12 mg.
English: In the pooled adolescent schizophrenia population (12 years and older, N = 545) exposed to INVEGA, the frequency and type of undesirable effects were similar to those in adults except for the following ADRs that were reported more frequently in adolescents receiving INVEGA than adults receiving INVEGA (and more frequently than placebo): sedation/somnolence, parkinsonism, weight increase, upper respiratory tract infection, akathisia, and tremor were reported very commonly (≥ 1/10) in adolescents; abdominal pain, galactorrhoea, gynaecomastia, acne, dysarthria, gastroenteritis, epistaxis, ear infection, blood triglyceride increased, and vertigo were reported commonly (≥ 1/100, < 1/10) in adolescents.
Croatian: U združenoj populaciji adolescenata sa shizofrenijom (12 godina i starijih, N = 545) izloženih lijeku INVEGA, učestalost i tip nuspojava bili su slični onima uočenima u odraslih, osim za slijedeće nuspojave koje su prijavljene češće u adolescenata koji uzimaju lijek INVEGA, nego u odraslih koji uzimaju lijek INVEGA (i češće nego za placebo): sedacija/somnolencija, parkinsonizam, povećana tjelesna težina, infekcija gornjih dišnih puteva, akatizija i tremor bili su prijavljeni vrlo često (≥ 1/10) u adolescenata; bol u abdomenu, galaktoreja, ginekomastija, akne, disartrija, gastroenteritis, epistaksa, infekcija uha, povišeni trigliceridi u krvi i vrtoglavica bili su prijavljeni često (≥ 1/100, < 1/10) u adolescenata.
English: Response defined as decrease from baseline in PANSS Total Score ≥ 30% and CGI-C Score ≤ 2
Croatian: Odgovor je definiran kao smanjenje u odnosu na početnu vrijednost u PANSS ukupnom rezultatu ≥ 30% i CGI-C rezultat
English: flatulence pancreatitis c,
Croatian: sindrom ustezanja c,
English: For adolescents weighing less than 51 kg the dose may be increased to 6 mg once a day.
Croatian: Za adolescente težine manje od 51 kg doza se može povisiti na do 6 mg jedanput na dan.
English: Paliperidone should be used with caution in patients with possible prolactin-dependent tumours.
Croatian: Paliperidon treba primijenjivati s oprezom kod bolesnika s mogućim prolaktin ovisnim tumorom.
English: Across all adolescent studies, EPS was more common in adolescents than in adults for each INVEGA dose.
Croatian: U svim ispitivanjima u adolescenata, za svaku od doza lijeka INVEGA, EPS je bio češći u adolescenata nego u odraslih.
English: The following symptoms may occur in newborn babies of mothers that have used paliperidone in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
Croatian: U novorođenčadi čije su majke uzimale paliperidon u zadnjem tromjesečju trudnoće opaženi su sljedeći simptomi: tresavica, ukočenost i/ili slabost mišića, pospanost, uznemirenost, problemi s disanjem i poteškoće pri hranjenju.
English: • pneumonia caused by inhaling food, congestion of breathing passages, voice disorder
Croatian: • upala pluća uzrokovana udisanjem hrane, začepljenje dišnih puteva, poremećaj glasa
English: Caution should be exercised when INVEGA is prescribed in patients with known cardiovascular disease or family history of QT prolongation, and in concomitant use with other medicines thought to prolong the QT interval.
Croatian: Potreban je oprez kad se INVEGA propisuje bolesnicima s poznatom bolešću srca i krvnih žila ili obiteljskom anamnezom produljenja QT intervala, kao i kod istodobne primjene lijekova koji produljuju QT.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e., essentially sodium-free.
Croatian: Ovaj lijek sadrži manje od 1 mmola natrija (23 mg) po tableti, tj. zanemarive količine natrija.
English: 59% of the dose was excreted unchanged into urine, indicating that paliperidone is not extensively metabolised by the liver.
Croatian: C-paliperidona s trenutnim otpuštanjem, 59% doze izlučeno je u urinu u nepromijenjenom obliku, što upućuje na činjenicu da se paliperidon ne metabolizira u velikoj mjeri u jetri.
English: These may be signs of a stroke.
Croatian: Ovo bi mogli biti znakovi moždanog udara.
English: Pack sizes of 14, 28, 30, 49, 56, and 98 prolonged-release tablets.
Croatian: Veličine pakiranja su od 14, 28, 30, 49, 56 i 98 tableta s produljenim oslobađanjem.
English: Bottles:
Croatian: Boce:
English: Patients with schizoaffective disorder treated with paliperidone should be carefully monitored for a potential switch from manic to depressive symptoms.
Croatian: Bolesnici sa shizoafektivnim poremećajem koji se liječe paliperidonom trebaju se pažljivo nadzirati zbog moguće promjene simptoma od maničnih na depresivne.
English: In schizophrenia clinical trials, increases in serum prolactin were observed with INVEGA in 67% of subjects.
Croatian: U kliničkim ispitivanjima provedenim kod shizofrenije uočeno je povećanje prolaktina u serumu kod 67% ispitanika koji su primali INVEGU.
English: For adolescents weighing 51 kg or more the dose may be increased within the range of 6 mg to 12 mg once a day.
Croatian: Za adolescente težine 51 kg ili više, doza se može povisiti u rasponu od 6 mg do 12 mg jedanput na dan.
English: Ear and labyrinth disorders vertigo, tinnitus, ear pain
Croatian: Poremećaji uha i labirinta vertigo, tinitus, bol u uhu
English: Antipsychotic medicinal products (including risperidone) with α-adrenergic blocking effects have been reported to induce priapism.
Croatian: Zabilježeno je da antipsihotici (uključujući risperidon) s blokirajućim djelovanjem na α-adrenergičke receptore mogu izazvati prijapizam.
English: These tumours can be related to prolonged dopamine D2 antagonism and hyperprolactinemia.
Croatian: Ti se tumori mogu povezati s produljenim antagonizmom dopamin D2 receptora i hiperprolaktinemijom.
English: In schizoaffective disorder clinical trials, a higher percentage of INVEGA-treated subjects (5%) had an increase in body weight of ≥ 7% compared with placebo-treated subjects (1%).
Croatian: U kliničkim ispitivanjima kod bolesnika s shizoafektivnim poremećajem veći je postotak ispitanika na terapiji lijekom INVEGA (5%) imao povećanje tjelesne težine za ≥ 7% u usporedbi s ispitanicima koji su primali placebo (1%).
English: Co-administration of INVEGA with divalproex sodium prolonged-release tablets increased the exposure to paliperidone (see below).
Croatian: Istodobna primjena INVEGE jednom dnevno i tableta s produljenim oslobađanjem divalproeksnatrija povećala je izloženost paliperidonu (vidjeti niže).
English: The following are all the ADRs that were reported in clinical trials and post-marketing experience with paliperidone by frequency category estimated from INVEGA clinical trials in adults.
Croatian: U daljnjem tekstu navedene su sve nuspojave prijavljene u kliničkim ispitivanjima i nakon stavljanja lijeka u promet paliperidona prema kategoriji učestalosti iz kliničkih ispitivanja lijeka INVEGA u odraslih.
English: In the study that examined two dose groups (see section 5.1), the increase in body weight of ≥ 7% was 3% in the lower-dose (3-6 mg) group, 7% in the higher-dose (9-12 mg) group, and 1% in the placebo group.
Croatian: U ispitivanju koje je obuhvaćalo dvije dozne skupine (vidjeti dio 5.1), povećanje tjelesne težine za ≥ 7% imalo je 3% ispitanika u skupini koja je primala nižu dozu (3-6 mg), 7% u skupini koja je primala višu dozu (9-12 mg) te 1% u skupini koja je primala placebo.
English: Pack sizes of 14, 28, 49, 56, and 98 prolonged-release tablets.
Croatian: Veličine pakiranja su od 14, 28, 49, 56 i 98 tableta s produljenim oslobađanjem.
English: CARTON FOR OPA-ALUMINIUM-PVC/ALUMINIUM BLISTER
Croatian: KUTIJA ZA OPA-ALUMINIJ-PVC/ALUMINIJ
English: 7 TABLET OPA-ALU-PVC/ALU BLISTER
Croatian: OPA-AL-PVC/AL BLISTER SA 7 TABLETA
English: After having been successfully treated for an acute psychotic or mood episode for 13 weeks and stabilised for an additional 12 weeks with the long-acting injectable formulation of paliperidone (doses ranging from 50 to 150 mg) patients were then randomised to a 15-month double-blind relapse prevention period of the study to either continue on the long-acting injectable formulation of paliperidone or on placebo until they experienced a relapse of schizoaffective symptoms.
Croatian: Nakon 13 tjedana uspješnog liječenja akutne psihotične epizode ili epizode poremećaja raspoloženja, te nakon stabilizacije tijekom dodatnih 12 tjedana s dugodjelujućom formulacijom paliperidona u obliku injekcije (doze u rasponu od 50 do 150 mg), bolesnici su nastavili u 15-mjesečni dvostruko-slijepi period ispitivanja prevencije relapsa, gdje su randomizirani bilo u skupinu koja je nastavila s primjenom dugodjelujuće formulacije paliperidona u obliku injekcije ili u skupinu s placebom, do relapsa shizoafektivnih simptoma.
English: Cases of venous thromboembolism, including cases of pulmonary embolism and cases of deep vein thrombosis have been reported with antipsychotic drugs - Frequency unknown.
Croatian: Uz liječenje antipsihoticima zabilježeni su slučajevi venske tromboembolije, uključujući slučajeve plućne embolije i slučajeve duboke venske tromboze - nepoznate učestalosti.
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucosegalactose malabsorption should not take this medicine.
Croatian: Sadržaj laktoze (odnosi se samo na tablete od 3 mg) Bolesnici s rijetkim nasljednim poremećajem nepodnošenja galaktoze, nedostatkom Lapp laktaze ili malapsorpcijom glukoze i galaktoze ne bi trebali uzimati ovaj lijek.
English: INVEGA is indicated for the treatment of schizophrenia in adults and in adolescents 15 years and older.
Croatian: INVEGA je indicirana za liječenje shizofrenije u odraslih i u adolescenata od 15 godina i starijih.
English: INVEGA is used to treat schizophrenia in adults and in adolescents aged 15 years and older.
Croatian: INVEGA se koristi za liječenje shizofrenije u odraslih i adolescenata od 15 godina i starijih.
English: • a delay in menstrual periods, breast enlargement
Croatian: • kašnjanje menstruacije, povećanje dojki
English: For patients with mild renal impairment (creatinine clearance ≥ 50 to < 80 mL/min), the recommended initial dose is 3 mg once daily.
Croatian: Kod bolesnika s blagim oštećenjem bubrega (klirens kreatinina ≥ 50 do < 80 ml/min) preporučuje se početna doza od 3 mg jedanput dnevno.
English: Each bottle contains two 1 g dessicant silica gel (silicone dioxide) pouches (pouch is food approved polyethylene).
Croatian: Jedna boca sadrži dvije vrećice (od odobrenog prehrambenog aditiva polietilena) s 1 g sredstva za sušenje, silika gela (silicijev dioksid).
English: In the short-term, placebo-controlled, fixed-dose adolescent study, a higher percentage of INVEGA-treated subjects (6-19% depending on dose) had an increase in body weight of ≥ 7% compared to placebo-treated subjects (2%).
Croatian: U kratkotrajnom, placebom-kontroliranom ispitivanju fiksne doze u adolescenata, viši postotak ispitanika liječenih lijekom INVEGA (6-19% ovisno o dozi) imalo je povećanu tjelesnu težinu od ≥ 7% u uspredbi s ispitanicima koji su primali placebo (2%).
English: Co-administration of a single dose of INVEGA 12 mg with divalproex sodium prolonged-release tablets (two 500 mg tablets once daily) resulted in an increase of approximately 50% in the Cmax and AUC of paliperidone.
Croatian: Istovremena primjena jedne doze INVEGE od 12 mg s divalproeksnatrij tabletama s produljenim oslobađanjem (dvije tablete od 500 mg jednom dnevno) dovela je do povećanja Cmax i AUC paliperidona za oko 50%.
English: In the schizoaffective disorder studies, a greater proportion of subjects in the total INVEGA dose group who were receiving concomitant therapy with an antidepressant or mood stabiliser experienced adverse events as compared to those subjects treated with INVEGA monotherapy.
Croatian: U ispitivanjima provedenim u bolesnika s shizoafektivnim poremećajem, veći dio ispitanika iz skupine s ukupnom dozom lijeka INVEGA koji su konkomitantno uzimali antidepresive ili stabilizatore raspoloženja, imalo je nuspojave u odnosu na ispitanike koji su bili na monoterapiji lijekom INVEGA.
English: • lung congestion
Croatian: • plućna kongestija
English: 30 prolonged-release tablets 350 prolonged-release tablets
Croatian: 30 tableta s produljenim oslobađanjem 350 tableta s produljenim oslobađanjem
English: INVEGA should be used with caution in elderly patients with dementia with risk factors for stroke (see section 4.4).
Croatian: Lijek INVEGA mora se primjenjivati uz oprez kod starijih dementnih bolesnika s faktorima rizika za pojavu moždanog udara (vidjeti dio 4.4).
English: Although in vitro studies suggested a role for CYP2D6 and CYP3A4 in the metabolism of paliperidone, there is no evidence in vivo that these isozymes play a significant role in the metabolism of paliperidone.
Croatian: Iako in vitro ispitivanja upućuju na to da CYP2D6 i CYP3A4 sudjeluju u metabolizmu paliperidona, ne postoje in vivo dokazi da ti izoenzimi imaju važnu ulogu u metabolizmu paliperidona.
English: • eye infection, fungal infection of the nails, infection of the skin, skin inflammation caused by mites
Croatian: • infekcija oka, gljivična infekcija noktiju, infekcija kože, upala kože uzrokovana grinjama
English: The INVEGA group in the flexible-dose study (dosed between 3 and 12 mg/day, mean modal dose of 8.6 mg/day) and the higher dose group of INVEGA in the 2 dose-level study (12 mg/day with option to reduce to 9 mg/day) were each superior to placebo in the PANSS at 6 weeks.
Croatian: U 6. tjednu ispitivanja, u skupini s fleksibilnim doziranjem lijeka INVEGA (doziranje u rasponu 3 i 12 mg/dnevno, srednja modalna doza od 8,6 mg/danu) i skupini s većom dozom lijeka INVEGA u ispitivanju 2 doze lijeka (12 mg dnevno s mogućnošću smanjenja na 9 mg dnevno), obje su skupine bile superiornije spram placeba prema rezultatu PANSS ljestvice.
English: Undesirable effects noted with risperidone formulations Paliperidone is the active metabolite of risperidone, therefore, the adverse reaction profiles of these compounds (including both the oral and injectable formulations) are relevant to one another.
Croatian: Paliperidon je aktivni metabolit risperidona, stoga je profil nuspojava ovih tvari (uključujući oralne formulacije i one koje se primjenjuju injekcijom) međusobno povezan.
English: INVEGA contains sodium
Croatian: INVEGA sadrži natrij
English: Co-administration of INVEGA once daily with carbamazepine 200 mg twice daily caused a decrease of approximately 37% in the mean steady-state Cmax and AUC of paliperidone.
Croatian: Istodobna primjena INVEGE jednom dnevno i karbamazepina u dozi od 200 mg dva puta dnevno uzrokovala je sniženje prosječnog Cmax i AUC paliperidona u stanju dinamičke ravnoteže za oko 37%.
English: • parkinsonism: This condition may include slow or impaired movement, sensation of stiffness or tightness of the muscles (making your movements jerky), and sometimes even a sensation of movement "freezing up" and then restarting.
Croatian: • parkinsonizam: Ovo stanje može uključiti sporost pri kretanju ili oštećeno kretanje, osjećaj krutosti ili stegnutosti mišića (što uzrokuje trzajne pokrete), a ponekad čak i pokrete uz
English: The patient should be instructed to always take INVEGA in the fasting state or always take it together with breakfast and not to alternate between administration in the fasting state or in the fed state.
Croatian: Bolesnika je potrebno savjetovati da uvijek uzimaju lijek INVEGA ili na prazan želudac ili zajedno s doručkom, te da ne mijenjaju način uzimanja lijeka tj. da ga uzimaju ili na prazan želudac ili uz obrok.
English: Placebo) Diff. of LS Means (SE)
Croatian: Placebo) Razlika najmanjih kvadrata (SE)
English: Mean baseline (SD) Mean change (SD) P-value (vs.
Croatian: Srednja početna vrijednost (SD) Srednja vrijednost promjene (SD) P vrijednost (vs.
English: • high blood triglycerides (a fat)
Croatian: • visoki trigliceridi u krvi (masnoća)
English: Infections and infestations bronchitis, upper respiratory tract infection, sinusitis, urinary tract infection, influenza pneumonia, respiratory tract infection, cystitis, ear infection, tonsillitis eye infection, onychomycosis, cellulitis, acarodermatitis
Croatian: Infekcije i infestacije bronhitis, infekcija gornjih dišnih puteva, sinusitis, infekcija urinarnog trakta, influenca pneumonija, infekcija dišnog sustava, cistitis, infekcija uha, tonzilitis infekcija oka, onihomikoza, celulitis, akarodermatitis
English: • infection of the chest (bronchitis), common cold symptoms, sinus infection, urinary tract infection, feeling like you have the flu
Croatian: • infekcija prsišta (bronhitis), uobičajeni simptomi prehlade, infekcija sinusa, infekcija mokraćnih puteva, osjećaj gripe
English: If you need to have cataract surgery, be sure to tell your eye doctor if you take or have taken this medicine.
Croatian: Ako trebate ići na opraciju katarakte, obavezno obavijestite svog liječnika oftalmologa da uzimate ovaj lijek.
English: Adolescents weighing < 51 kg: the maximum recommended daily dose of INVEGA is 6 mg.
Croatian: Adolescenti težine < 51 kg: maksimalna preporučena dnevna doza lijeka INVEGA je 6 mg.
English: EPS included a pooled analysis of the following terms: Parkinsonism (includes salivary hypersecretion, musculoskeletal stiffness, parkinsonism, drooling, cogwheel rigidity, bradykinesia, hypokinesia, masked facies, muscle tightness, akinesia, nuchal rigidity, muscle rigidity, parkinsonian gait, and glabellar reflex abnormal, parkinsonian rest tremor), akathisia (includes akathisia, restlessness, hyperkinesia, and restless leg syndrome), dyskinesia (dyskinesia, muscle twitching, choreoathetosis, athetosis, and myoclonus), dystonia (includes dystonia, hypertonia, torticollis, muscle contractions involuntary, muscle contracture, blepharospasm, oculogyration, tongue paralysis, facial spasm, laryngospasm, myotonia, opisthotonus, oropharyngeal spasm, pleurothotonus, tongue spasm, and trismus), and tremor.
Croatian: EPS je uključio objedinjenu analizu sljedećih izraza: parkinsonizam (koji uključuje hipersekreciju sline, mišićno-koštanu ukočenost, parkinsonizam, slinjenje, rigidnost s fenomenom zupčanika, bradikineziju, hipokineziju, izraz lica u obliku maske, mišićnu napetost, akineziju, nuhalni rigiditet, rigiditet mišića, hod tipičan za parkinsonizam, abnormalan glabelarni refleks te parkinsonski tremor u mirovanju), akatizija (uključuje akatiziju, nemir, hiperkineziju i sindrom nemirnih nogu), diskinezija (diskinezija, mišićni trzaji, koreoatetoza, atetoza i mioklonus), distonija (uključuje distoniju, hipertoniju, tortikolis, nevoljne mišićne kontrakcije, kontrakturu mišića, blefarospazam, okulogiraciju, paralizu jezika, spazam lica, laringospazam, miotoniju, opistotonus, orofaringealni spazam, pleurototonus, spazam jezika i trizmus), te tremor.
English: Psychiatric disorders: sleep-related eating disorder Nervous system disorders: cerebrovascular disorder Eye disorders: floppy iris syndrome (intraoperative) Respiratory, thoracic and mediastinal disorders: rales
Croatian: Psihijatrijski poremećaji: poremećaj hranjenja povezan sa spavanjem Poremećaji živčanog sustava: cerebrovaskularni poremećaj Poremećaji oka: sindrom meke šarenice (intraoperacijski) Poremećaji dišnog sustava, prsišta i sredoprsja: krepitacije
English: No data are available in patients with a creatinine clearance below 10 mL/min.
Croatian: Podaci o bolesnicima s klirensom kreatinina ispod 10 ml/min nisu dostupni.
English: The efficacy of INVEGA in the treatment of schizophrenia in adolescents between 12 and 14 years old has not been established.
Croatian: Djelotvornost lijeka INVEGA u liječenju shizofrenije u adolescenata dobi između 12 i 14 godina nije ustanovljena.
English: When dose increases are indicated, increments of 3 mg/day are recommended and generally should occur at intervals of 5 days or more.
Croatian: Kada je indicirano povećanje doze, preporučeno je povećanje od 3 mg/dan te se, obično, mora provoditi u intervalima od 5 ili više dana.
English: QT prolongation, ventricular arrythmias (ventricular fibrillation, ventricular tachycardia), sudden unexplained death, cardiac arrest and Torsade de pointes may occur with antipsychotics.
Croatian: Kod primjene antipsihotika može doći do produljenja QT intervala, ventrikularnih aritmija (ventrikularne fibrilacije, ventrikularne tahikardije), iznenadne neobjašnjive smrti, zastoja srca i torsade de pointes.
English: In addition to the above adverse reactions, the following adverse reactions have been noted with the use of risperdone products and can be expected to occur with INVEGA.
Croatian: Dodatno, uz iznad navedene nuspojave, slijedeće nuspojave zabilježene su pri uzimanju lijekova s risperidonom te se mogu očekivati uz INVEGU.
English: - if you know that you have had low levels of white blood cells in the past (which may or may not have been caused by other medicines).
Croatian: Morate biti svjesni da oba gore navedena stanja mogu biti uzrokovana lijekovima koji pripadaju ovoj skupini lijekova. - ako znate da ste ikada u prošlosti imali nisku razinu bijelih krvnih stanica (koja je mogla biti uzrokovana drugim lijekovima ili na nju nisu utjecali drugi lijekovi). - ako imate šećernu bolest ili sklonost za šećernu bolest.
English: Caution is advised if paliperidone is combined with other medicines known to lower the seizure threshold (i.e., phenothiazines or butyrophenones, clozapine, tricyclics or SSRIs, tramadol, mefloquine, etc.).
Croatian: Preporučuje se oprez ako se paliperidon primjenjuje zajedno s drugim lijekovima za koje je poznato da smanjuju konvulzivni prag (tj. fenotijazinima ili butirofenonima, klozapinom, tricikličkim antidepresivima ili selektivnim inhibitorima ponovne pohrane serotonina, tramadolom, melflokinom, itd.).
English: The 3 mg tablets are white and printed with “PAL 3”, the 6 mg tablets are beige and printed with “PAL 6”, the 9 mg tablets are pink and printed with “PAL 9”, and the 12 mg tablets are dark yellow and printed with “PAL 12”.
Croatian: Tablete od 3 mg su bijele s otisnutom oznakom „PAL 3”, tablete od 6 mg su bež boje s otisnutom oznakom „PAL 6”, tablete od 9 mg su roze s otisnutom oznakom „PAL 9”, a tablete od 12 mg su tamnožute s otisnutom oznakom „PAL 12”.
English: Pharmacologic group: Psycholeptics, other antipsychotics ATC code: N05AX13
Croatian: ATK oznaka: N05AX13
English: Not observed in INVEGA clinical studies but observed in post-marketing environment with paliperidone In placebo-controlled pivotal trials, diabetes mellitus was reported in 0.05% in INVEGA-treated subjects compared to a rate of 0% in placebo group.
Croatian: U placebo-kontroliranim pivotalnim ispitivanjima, dijabetes melitus je bio prijavljen u 0,05% ispitanika liječenih INVEGOM u usporedbi sa stopom od 0% u placebo skupini.
English: The recommended dose in adults is 6 mg once a day taken in the morning.
Croatian: Preporučena doza za odrasle je 6 mg jedanput dnevno i uzima se ujutro.
English: • breast swelling in boys
Croatian: • oticanje dojki kod dečki
English: Rare side effects: may affect up to 1 in 1,000 people
Croatian: Rijetke nuspojave: mogu utjecati na do 1 na 1000 osoba
English: If you forget to take INVEGA
Croatian: Ako ste zaboravili uzeti lijek INVEGA
English: Some patients may benefit from lower or higher doses within the recommended range of 3 mg to 12 mg once daily.
Croatian: Neki će bolesnici imati koristi od nižih ili viših doza unutar preporučenog raspona od 3 do 12 mg jedanput dnevno.
English: - if you have an abnormally high level of the hormone prolactin in your blood or if you have a possible prolactin-dependent tumour.
Croatian: - ako imate abnormalno visoku razinu hormona prolaktina u krvi ili potencijalno imate o prolaktinu ovisan tumor. - ako Vi ili netko u Vašoj obitelji ima u povijesti bolesti pojavu krvnih ugrušaka, obzirom da su antipsihotici povezani s nastankom krvnih ugrušaka.